Reaction Details |
| Report a problem with these data |
Target | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A |
---|
Ligand | BDBM50602385 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_2240249 (CHEMBL5154145) |
---|
IC50 | 13±n/a nM |
---|
Citation | Meibom, D; Micus, S; Andreevski, AL; Anlauf, S; Bogner, P; von Buehler, CJ; Dieskau, AP; Dreher, J; Eitner, F; Fliegner, D; Follmann, M; Gericke, KM; Maassen, S; Meyer, J; Schlemmer, KH; Steuber, H; Tersteegen, A; Wunder, F BAY-7081: A Potent, Selective, and Orally Bioavailable Cyanopyridone-Based PDE9A Inhibitor. J Med Chem65:16420-16431 (2022) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A |
---|
Name: | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A |
Synonyms: | 3',5'-cyclic phosphodiesterase | PDE9A | PDE9A_HUMAN | Phosphodiesterase 9A | Phosphodiesterase 9A (PDE9) | Phosphodiesterase 9A (PDE9A) |
Type: | Protein |
Mol. Mass.: | 68488.40 |
Organism: | Homo sapiens (Human) |
Description: | O76083 |
Residue: | 593 |
Sequence: | MGSGSSSYRPKAIYLDIDGRIQKVIFSKYCNSSDIMDLFCIATGLPRNTTISLLTTDDAM
VSIDPTMPANSERTPYKVRPVAIKQLSAGVEDKRTTSRGQSAERPLRDRRVVGLEQPRRE
GAFESGQVEPRPREPQGCYQEGQRIPPEREELIQSVLAQVAEQFSRAFKINELKAEVANH
LAVLEKRVELEGLKVVEIEKCKSDIKKMREELAARSSRTNCPCKYSFLDNHKKLTPRRDV
PTYPKYLLSPETIEALRKPTFDVWLWEPNEMLSCLEHMYHDLGLVRDFSINPVTLRRWLF
CVHDNYRNNPFHNFRHCFCVAQMMYSMVWLCSLQEKFSQTDILILMTAAICHDLDHPGYN
NTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLI
LATDMARHAEIMDSFKEKMENFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCL
LEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGFIKFVLIPMFETVTKLFPMVEEIML
QPLWESRDRYEELKRIDDAMKELQKKTDSLTSGATEKSRERSRDVKNSEGDCA
|
|
|
BDBM50602385 |
---|
n/a |
---|
Name | BDBM50602385 |
Synonyms: | CHEMBL5174546 |
Type | Small organic molecule |
Emp. Form. | C18H22N2O |
Mol. Mass. | 282.3801 |
SMILES | CCCC1CCCc2c(nc(=O)[nH]c12)-c1ccc(C)cc1 |
Structure |
|